Suppr超能文献

成人腰痛治疗药物。对乙酰氨基酚、阿片类药物、非甾体抗炎药、肌肉松弛剂、抗生素和抗抑郁药的使用证据:肌肉骨骼临床医生概述。

Medications for Treating Low Back Pain in Adults. Evidence for the Use of Paracetamol, Opioids, Nonsteroidal Anti-inflammatories, Muscle Relaxants, Antibiotics, and Antidepressants: An Overview for Musculoskeletal Clinicians.

出版信息

J Orthop Sports Phys Ther. 2022 Jul;52(7):425-431. doi: 10.2519/jospt.2022.10788. Epub 2022 May 18.

Abstract

BACKGROUND

Because pharmacological therapies may play an important role in managing musculoskeletal pain, the appropriate use of medicines for common conditions like low back pain (LBP) is critical. New evidence on the effects and safety of paracetamol, nonsteroidal anti-inflammatory drugs (NSAIDs), opioid analgesics, muscle relaxants, antibiotics, and antidepressants for LBP warrants an updated overview for musculoskeletal clinicians on this topic.

CLINICAL QUESTION

How effective and safe are paracetamol, NSAIDs, opioid analgesics, muscle relaxants, antibiotics, and antidepressants compared with placebo for treating LBP?

KEY RESULTS

For acute LBP (<12 weeks), muscle relaxants and NSAIDs may be superior to placebo for reducing pain, but the effects of opioids, antibiotics, and antidepressants are unknown. Paracetamol provides no additional benefit for acute LBP. For chronic LBP (>12 weeks), NSAIDs, antidepressants, and opioids may be superior to placebo for reducing pain, but opioids have an established profile of harms. Antibiotics may also reduce pain for people with chronic LBP with Modic type 1 changes, although the risks may outweigh their benefits. The effects of paracetamol and muscle relaxants for chronic LBP were unclear.

CLINICAL APPLICATION

NSAIDs may have a role in managing acute and chronic LBP, with cautious use in people who may be at greater risk of experiencing adverse events. Paracetamol, opioid analgesics, antibiotics, muscle relaxants, and antidepressants should only be prescribed following a discussion between the treating clinician and the patient, considering the risks and possible benefits, and after or in conjunction with recommended nonpharmacological strategies for improving LBP. .

摘要

背景

由于药物治疗在管理肌肉骨骼疼痛方面可能发挥着重要作用,因此对于常见疾病(如腰痛),合理使用药物至关重要。有关对乙酰氨基酚、非甾体抗炎药 (NSAIDs)、阿片类镇痛药、肌肉松弛剂、抗生素和抗抑郁药治疗腰痛的效果和安全性的新证据,要求肌肉骨骼临床医生对此进行更新概述。

临床问题

与安慰剂相比,对乙酰氨基酚、非甾体抗炎药、阿片类镇痛药、肌肉松弛剂、抗生素和抗抑郁药治疗腰痛的效果和安全性如何?

主要结果

对于急性腰痛(<12 周),肌肉松弛剂和 NSAIDs 可能比安慰剂更能减轻疼痛,但阿片类药物、抗生素和抗抑郁药的效果未知。对乙酰氨基酚对急性腰痛没有额外的益处。对于慢性腰痛(>12 周),NSAIDs、抗抑郁药和阿片类药物可能比安慰剂更能减轻疼痛,但阿片类药物已确定存在危害。对于患有 Modic 型 1 改变的慢性腰痛患者,抗生素也可能减轻疼痛,但风险可能超过获益。对乙酰氨基酚和肌肉松弛剂治疗慢性腰痛的效果尚不清楚。

临床应用

在可能存在发生不良反应风险较高的人群中,NSAIDs 可能在管理急性和慢性腰痛方面具有一定作用,需谨慎使用。在与治疗医生进行讨论后,考虑到风险和可能的获益,并在建议的改善腰痛的非药物策略之后或同时,只有在患者知情同意的情况下,方可开处方使用对乙酰氨基酚、阿片类镇痛药、抗生素、肌肉松弛剂和抗抑郁药。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验